Abstract
Introduction

56
Spinal cord injury (SCI) leads to a myriad of acute and chronic urinary 57 complications that have detrimental effects on overall health and quality of life (1).
58
Urinary complications after injury are viewed by the SCI population as one of the most 59 significant disruptions negatively impacting quality of life (1). One important yet poorly 60 understood urinary complication following SCI is polyuria -the excess production of 61 and/or passage of urine (9, 47) . Amplification of urine production after SCI further 62 burdens an already difficult daily bladder management program with a need for more 63 catheterizations especially at night, contributing to disruption of sleep and thus daily 64 activities. Countering this excess urine production with the restriction of fluid intake, 65 including in the evening prior to bedtime, poses a significant health concern. The 66 prevalence of polyuria in the SCI population has not been reported, although studies 67 investigating nocturnal polyuria (excessive nightly urine production) within the SCI 68 population has shown that the prevalence of this condition may be up to 81% (6).
69
Although several studies have documented the occurrence of polyuria in human 70 SCI and rodent spinal contusion models (9, 14, 17, 42, 47) , little research has been 71 done to identify underlying causes/mechanisms. One potential contributor is the 72 hormone arginine vasopressin (AVP), a major regulator of fluid balance in the body (19).
73
AVP (also known as antidiuretic hormone) is released from the posterior pituitary in 74 response to changes in blood osmolality. It acts in the kidney by binding to V2 75 receptors in the collecting ducts, which then leads to the transposition of aquaporin 2 76 receptors to the serum membrane thereby allowing water to be reabsorbed back into 77 the blood. AVP levels follow a diurnal cycle, with levels increased during the night (45) 78 to prevent the need to awaken for urination. Several human SCI studies (17, 42) have 79 shown that increased urine production occurs at night (nocturia) along with evidence 80 that the normal nightly increase in AVP levels is absent at chronic post-injury stages.
81
Increased urine production in the rodent contusion model on a 12 hour light-dark cycle 82 occurs throughout the 24 hour period (as measured using metabolic cages) (14, 47) , 83 suggesting that AVP should be decreased throughout the day if AVP levels contribute to 84 SCI induce polyuria in our model.
85
Although there is initial strong evidence for SCI-induced polyuria and a potential 86 role of changing serum AVP levels, the factor(s) that precipitate the development of this 87 condition have yet to be elucidated. Potential mechanisms by which AVP levels may be 88 decreased following SCI are also unknown. Blood osmolality is the primary stimulator 89 for AVP release (7, 31) , but there are a number of non-osmotic stimuli that also 90 influence the release of AVP into the blood stream including glucocorticoids, 91 norepinephrine (NE), atrial natriuretic peptide (ANP), and brain natriuretic peptide (BNP) 92 (8, 26, 27, 35, 48, 49) . Some of these factors that can effect AVP release, such as 93 glucocorticoids and natriuretic peptides, are known to increase urine output (11, 13, 15, 94 43). Increased levels of glucocorticoids significantly increase glomerular filtration rate increase urine production not only through suppression of AVP release but also through 99 direct effects on the kidneys (13, 15, 39, 50) Franklin Lakes, NJ) from animals via tail vein draw pre-injury (as a baseline measure) 163 and then post-injury (10 days following injury) for measurement of serum AVP levels.
164
Samples were centrifuged for 15 minutes at 14000 g and then the serum was removed. Pre-injury and post-injury serum vasopressin levels were measured using an
182
Arginine Vasopressin EIA kit (Cayman Chemical, Ann Arbor, MI, catalog # 583951).
183
The AVP detection range for the kit was 3,000 -23.4 pg/ml. Prior to testing, serum 184 samples were purified using C-18 solid phase extraction (SPE) columns (Thermo 
191
Urinary corticosterone (CORT) levels were measured using a Corticosterone were carried out to compare pre-injury and post-injury levels using SigmaStat version Urine output after Following SCI, the total urine volume excreted over a 24 hour period was 279 significantly increased (t = -9.82, p ≤ 0.001) compared to baseline pre-injury levels ( 
302
The urine specific gravity (SG) was also significantly decreased following SCI
303
(pre-injury = 1.028 +/-0.001 and post-injury = 1.020 +/-0.001; t = 6.036, p ≤ 0.001). SG 304 is the ratio of urine density compared to water and is determined by the concentration of 305 solutes, including sodium, in urine (8). It is often used as a measure of urine 306 concentration, and the closer the value is to 1 the more water-like and less concentrated 307 it is. There was no change in SG in the surgical sham control group relative to baseline. were from different batches).
317
The strongest regulator of AVP levels is serum osmolality. To begin to elucidate 318 the mechanisms which may influence AVP levels following SCI, serum osmolality was 319 also measured in pre-and post-injury samples. Although serum osmolality was 320 significantly different after injury (t = -3.48, p = 0.001), the change was in a direction that 321 would lead to an increase in AVP levels under normal physiological conditions (Fig. 2B) . Non-osmotic factors that can influence AVP levels include corticosterone 327 (CORT), a stress-related hormone (30). Increased CORT levels are known to suppress 328 the release of AVP from the hypothalamus and thus an increase in CORT after SCI 329 could be a contributing factor to the suppression of AVP that was observed in these 330 animals post-SCI (30, 35). Urinary CORT levels were observed to be increased by 331 47.3% at two weeks following SCI (Fig. 3A, t 
343
Another potential regulator of AVP levels are natriuretic peptides (ANP and 344 BNP). As with CORT and NE, an increase in ANP and BNP can suppress AVP release 345 from the hypothalamus leading to decreased serum AVP levels (8, 27, 49).
346
Interestingly, in our cohort of subjects, the urinary levels of atrial natriuretic peptide was 347 significantly elevated relative to pre-injury baseline at the two week post-SCI time-point 348 (ANP: t = -2.73, p = 0.005) (Fig. 4A) , whereas ANP levels in the control animals was not to identify interrelationships between these substrates at two weeks following SCI.
359
When all factors were added to the PCA, four components accounted for 81% of the 360 variance seen in the analysis (Fig. 5) . The first two components accounted for over 361 50% of the variance (53.8%). In Component 1, 24 hour urine volume, CORT and ANP 362 levels at two weeks post-injury had a strong positive influence on this component with
363
Cre and SG levels having a strong negative influence within the same component.
364
Component 2 involved an inter-correlation between 24-hour drink volume and NE levels 365 post-injury. Component 3 (osmolality) and 4 (oliguria) accounted for 27.2% of the 366 variance (Fig. 5) .
368
Discussion
369
The results of this study further demonstrates the occurrence of polyuria to the overall development of polyuria following SCI, supporting the hypothesis that the 377 mechanism involved in the development of polyuria after SCI is multifactorial (Fig. 6) . was not enough to initiate these changes. Instead, it appears that the SCI itself is in 388 some way influencing AVP and ANP levels. 
SCI leads to changes in levels of hormones controlling fluid balance -
391
As revealed in the Results section, there are significant changes in the levels of 392 CORT, AVP and ANP at two weeks following SCI. As illustrated in Fig. 6 , the direction 393 of these changes (a decrease in AVP, and an increase in ANP) is such that the tightly 394 regulated fluid balance system is driven in the direction of polyuria (11, 13, 15, 43 increase in CORT and NE levels are known to suppress AVP secretion (3, 30, 35, 36) .
412
CORT levels have been shown to increase following SCI (21, 29) and such was the 413 case for the contused rats at a two-week post-SCI time-point in the present study. This 414 increase did not appear to be a result of surgery as the control animals that underwent a 415 surgical laminectomy without a SCI had no significant increases in CORT levels at the 416 same time-point. In contrast, NE levels were not significantly different following SCI or 417 laminectomy surgery. Thus, the increase in CORT levels following SCI may contribute 418 to the decreased levels of AVP seen at this same time point following SCI. Additionally, 419 increased CORT levels can directly increase urine output (11, 43), therefore increased 420 CORT levels post SCI may also contribute to SCI-induced polyuria independent of its 421 influence on AVP levels, although no correlation between CORT levels and urinary 422 output was found in this study. Future studies involving the administration of anti-423 glucocorticoids post-injury would begin to address the influence that increased CORT 424 has on SCI-induced polyuria and AVP levels following SCI.
425
The current results also reveal an increase in natriuretic peptide levels at two- Although a relationship was found between an increase in ANP and urine volume 438 following SCI, it is unclear whether this is due to direct effects of ANP on the kidney or 439 indirect effects of ANP on suppressing AVP secretion which in turn leads to polyuria.
440
The effect of ANP increase on the development of polyuria is most likely multifactorial, in endothelin-1 (ET-1) has also been shown to be a potent stimulator for natriuretic 462 peptide release (12, 22, 32, 33) . Although we did not measure ET-1 levels in this study,
463
there is evidence that ET-1 levels do increase after SCI (24, 28, 34) . Future studies will 464 investigate the extent to which systemic ET-1 levels change after SCI and whether 
